Hope for cancer with 1-year survival rate as existing drug shown to reduce death by 35%

A PILL already used to treat a rare disease could prolong the lives of women with aggressive ovarian cancer, a pivotal trial has found. The drug, relacorilant, was found to be far more effective than existing treatments, extending the lives of patients by 35 per cent - buying them precious time with loved ones. Experts say...